spot_img
HomeHealthMediFyr Fuels NAHSV Healthlinko’s First-Year Growth as Company Advances Toward International Scale

MediFyr Fuels NAHSV Healthlinko’s First-Year Growth as Company Advances Toward International Scale

NAHSV Healthlinko Private Limited today marked its first anniversary, highlighting a year of profitable growth, growing patient adoption and international expansion progress led by its flagship healthcare platform, MediFyr.

Since launching in April 2025, the company has focused on building technology-driven healthcare solutions designed to improve access, simplify care discovery and support patients through their medical journeys. According to the company, that approach has translated into meaningful operating progress within its first year.

MediFyr currently supports more than 2,000 patients each month, reflecting growing demand for the company’s healthcare access model. This growth contributed to ₹65 lakh in revenue in the last quarter of the previous financial year, which the company said represents strong early-stage traction.

NAHSV Healthlinko noted that these milestones were achieved as a profitable, bootstrapped company, without relying on external investment. Management said the company’s emphasis on disciplined growth and sustainable execution has helped establish a strong operating foundation for future scale.

Alongside MediFyr, the company has continued expanding its broader digital health portfolio, including Zerunio, WhatPregnant, HealthSetu and Unikorn, which support its long-term strategy across healthcare and wellness innovation.

As part of its next phase, NAHSV Healthlinko said expanding internationally will remain a major strategic priority. Through MediFyr, the company has already established hospital partnerships across Turkey, Egypt, Israel, Thailand, UAE and China, laying the foundation for broader cross-border healthcare access and global growth.

The company said these relationships are expected to support deeper international collaboration while expanding MediFyr’s presence in global markets.

“In year one, our focus was on building a model that works — commercially, operationally and in terms of user trust,” the company said in a statement. “In year two, the focus shifts toward scaling that model responsibly and expanding the opportunity ahead.”

Key priorities for the coming year include growing patient reach, strengthening provider partnerships, expanding digital infrastructure and increasing MediFyr’s global footprint.

With patient growth, profitable operations and international partnerships already in place, NAHSV Healthlinko said it sees significant opportunity as it moves into its next stage of growth.

spot_img